We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Steps Up Push to Speed Generics to Market
FDA Guidance Steps Up Push to Speed Generics to Market
As part of a broad effort to increase competition and lower drug prices, the FDA spelled out what it expects from sponsors of abbreviated new generic drug applications who are seeking early meetings to smooth the approval review process.